Zurcher Kantonalbank (Zurich Cantonalbank) Ligand Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 2,399 shares of LGND stock, worth $267,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,399

Previous 2,399 -0.0%

Holding current value

$267,632

Previous $240,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$68.53 - $87.91 $68 - $87	-1 Reduced 0.04%	2,399 $202,000
Q1 2024 Apr 25, 2024	SELL	$68.64 - $89.2 $13,865 - $18,018	-202 Reduced 7.76%	2,400 $175,000
Q4 2023 Jan 30, 2024	SELL	$49.57 - $72.63 $1,288 - $1,888	-26 Reduced 0.99%	2,602 $185,000
Q3 2023 Oct 25, 2023	SELL	$58.86 - $72.67 $4,473 - $5,522	-76 Reduced 2.81%	2,628 $157,000
Q2 2023 Aug 07, 2023	SELL	$69.53 - $79.33 $4,728 - $5,394	-68 Reduced 2.45%	2,704 $194,000
Q1 2023 May 08, 2023	BUY	$65.67 - $77.08 $61,532 - $72,223	937 Added 51.06%	2,772 $203,000
Q4 2022 Feb 01, 2023	SELL	$61.72 - $96.74 $30,613 - $47,983	-496 Reduced 21.28%	1,835 $122,000
Q2 2022 Aug 09, 2022	SELL	$74.52 - $117.06 $1,266 - $1,990	-17 Reduced 0.72%	2,331 $208,000
Q1 2022 Apr 21, 2022	BUY	$94.99 - $151.56 $19,187 - $30,615	202 Added 9.41%	2,348 $264,000
Q4 2021 Feb 01, 2022	BUY	$127.69 - $165.85 $57,971 - $75,295	454 Added 26.83%	2,146 $331,000
Q1 2021 May 03, 2021	SELL	$99.52 - $215.83 $52,347 - $113,526	-526 Reduced 23.72%	1,692 $258,000
Q4 2020 Jan 28, 2021	BUY	$80.55 - $106.05 $36,166 - $47,616	449 Added 25.38%	2,218 $221,000
Q2 2020 Jul 28, 2020	BUY	$68.28 - $123.65 $24,307 - $44,019	356 Added 25.19%	1,769 $198,000
Q1 2019 Apr 29, 2019	SELL	$105.93 - $142.47 $635 - $854	-6 Reduced 0.42%	1,413 $178,000
Q3 2018 Nov 09, 2018	BUY	$211.18 - $274.49 $19,639 - $25,527	93 Added 7.01%	1,419 $390,000
Q2 2018 Aug 06, 2018	BUY	$150.77 - $207.98 $33,923 - $46,795	225 Added 20.44%	1,326 $275,000
Q4 2017 Jan 31, 2018	BUY	$128.36 - $147.04 $46,081 - $52,787	359 Added 48.38%	1,101 $151,000
Q3 2017 Nov 08, 2017	BUY	$120.91 - $137.94 $89,715 - $102,351	742	742 $101,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Ligand Pharmaceuticals Inc Transaction History